MedPath

哈尔滨元化药业有限公司

Ownership
-
Established
2020-04-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

防风通圣丸

Approval Number
国药准字Z20054998
Approval Date
Dec 30, 2020
NMPA

Sulfasalazine Suppositories

Product Name
柳氮磺吡啶栓
Approval Number
国药准字H20067505
Approval Date
Dec 30, 2020
NMPA

麝香祛痛气雾剂

Approval Number
国药准字Z20043551
Approval Date
Jul 28, 2020
NMPA

Bifendate Tablets

Product Name
联苯双酯片
Approval Number
国药准字H23023078
Approval Date
Jul 22, 2020
NMPA

Ferrous Sulfate Tablets

Product Name
硫酸亚铁片
Approval Number
国药准字H23020500
Approval Date
May 31, 2020
NMPA

Atenolol Tablets

Product Name
阿替洛尔片
Approval Number
国药准字H23020112
Approval Date
May 18, 2020
NMPA

藿胆丸

Approval Number
国药准字Z23021237
Approval Date
Apr 20, 2020
NMPA

小儿清热止咳口服液

Approval Number
国药准字Z20053743
Approval Date
Apr 16, 2020
NMPA

健儿消食口服液

Approval Number
国药准字Z20044410
Approval Date
Apr 16, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.